Table 2: Treatment patterns between groups.
|
Young |
Elders
|
|
Chemotherapy schedule: Cisplatin-combination Carboplatin-combination Monotherapy |
52 (71%) 18 (24%) 3 (5%) |
4 (8%) 32 (68%) 11 (24%) |
0.0001 |
Kind of combination: Cisplatin-vinorelbine Cisplatin-pemetrexed Cisplatin-gemcitabine Cisplatin-docetaxel Cisplatin-etoposide Carboplatin-paclitaxel Carboplatin-vinorelbine Carboplatin-gemcitabine Carboplatin alone Vinorelbine alone Pemetrexed alone |
46 1 1 1 3 4 12 2 1 2 0 |
3 1 0 0 0 4 24 4 5 5 1 |
0.0001 |
Number of cycles: Mean (95% CI) SD |
4 (2-6) 1.0 |
4 (1-7) 1.2 |
0.538 |
Median RT dose (Gy) SD |
60 (20-66) 10 |
59 (8-66) 16 |
0.330 |
Total dose < 40 Gy 40-50 Gy > 50 Gy |
9 (12%) 2 (3%) 62 (85%) |
12 (25%) 4 (9%) 31 (66%) |
0.048 |
Fraction 1.8 2.0 3.0 4.0 |
49 (67%) 17 (24%) 6 (8%) 1 (1%) |
21 (46%) 12 (26%) 7 (14%) 7 (14%) |
0.028 |
Mediastinum included YES NO |
62 (85%) 11 (15%) |
32 (68%) 15 (32%) |
0.026 |